Overview
SCIENTIFIC SCORE
Possibly Effective
Based on 3 Researches
7.7
USERS' SCORE
Good
Based on 28 Reviews
8.1
Supplement Facts
Serving Size: 2 Softgels
Amount Per Serving
%DV
Calories
20
Total Fat
2 g
3%**
Saturated Fat
0.5 g
3%**
Polyunsaturated Fat
1 g
†
Monounsaturated Fat
0.5 g
†
Fish Oil Concentrate
2 g (2,000 mg)
†
Eicosapentaenoic Acid (EPA)
360 mg
†
Docosahexaenoic Acid (DHA)
240 mg
†
Top Medical Research Studies
8
We conducted a double-blind randomized controlled trial to understand how prenatal supplementation of docosahexaenoic acid (DHA) might influence infant health, particularly concerning the common cold. Pregnant women were given either a daily dose of 400 mg of DHA or a placebo starting at 18 to 22 weeks of gestation until childbirth.
Caregivers then reported on their infants’ health at 1, 3, and 6 months, sharing details about common illness symptoms. We found that DHA supplementation appeared to reduce the number of colds at one month and also seemed to lessen the duration of various cold symptoms in infants. Specifically, infants in the DHA group experienced fewer cold symptoms and had shorter durations of cough and wheezing.
While the overall occurrence of specific illness symptoms was similar between the DHA and placebo groups, DHA did bring about noteworthy benefits. At 1 month, infants in the DHA group had a 26% shorter duration of cough and 30% shorter wheezing; however, they experienced a longer duration of rash.
Furthermore, by the time the infants reached 3 months, those whose mothers took DHA were ill for 14% less time overall. At 6 months, the DHA group showed significantly reduced durations of several illness indicators, although they did experience longer episodes of vomiting.
This study suggests that prenatal DHA not only seems to impact the occurrence of colds in children but may also play a role in the duration of symptoms over the first half-year of life.
Caregivers then reported on their infants’ health at 1, 3, and 6 months, sharing details about common illness symptoms. We found that DHA supplementation appeared to reduce the number of colds at one month and also seemed to lessen the duration of various cold symptoms in infants. Specifically, infants in the DHA group experienced fewer cold symptoms and had shorter durations of cough and wheezing.
While the overall occurrence of specific illness symptoms was similar between the DHA and placebo groups, DHA did bring about noteworthy benefits. At 1 month, infants in the DHA group had a 26% shorter duration of cough and 30% shorter wheezing; however, they experienced a longer duration of rash.
Furthermore, by the time the infants reached 3 months, those whose mothers took DHA were ill for 14% less time overall. At 6 months, the DHA group showed significantly reduced durations of several illness indicators, although they did experience longer episodes of vomiting.
This study suggests that prenatal DHA not only seems to impact the occurrence of colds in children but may also play a role in the duration of symptoms over the first half-year of life.
Read More
7
We examined the MITIGATE study, focusing on the effects of icosapent ethyl (IPE), a purified omega-3 fatty acid, in adults with cardiovascular disease at risk for viral upper respiratory infections.
With about 16,500 participants, this clinical trial compared IPE treatment against usual care. The goal was to see if IPE could lessen the severity and impact of viral infections over six months.
Unfortunately, there was no significant evidence found that IPE improved outcomes for upper respiratory infections in this group.
With about 16,500 participants, this clinical trial compared IPE treatment against usual care. The goal was to see if IPE could lessen the severity and impact of viral infections over six months.
Unfortunately, there was no significant evidence found that IPE improved outcomes for upper respiratory infections in this group.
Read More
8
We investigated whether feeding infants formula supplemented with docosahexaenoic acid (DHA) and arachidonic acid (ARA) could impact the development of allergies and respiratory illnesses until age three.
In a well-structured, randomized, double-blind study, we followed children who received either supplemented or nonsupplemented formulas during their first year of life. Our findings showed that those on the DHA/ARA formula had significantly lower chances of developing upper respiratory infections and common allergic diseases.
Notably, the DHA/ARA group experienced a delayed onset and reduced incidence of respiratory issues, indicating potential benefits of early nutrition on long-term health.
In a well-structured, randomized, double-blind study, we followed children who received either supplemented or nonsupplemented formulas during their first year of life. Our findings showed that those on the DHA/ARA formula had significantly lower chances of developing upper respiratory infections and common allergic diseases.
Notably, the DHA/ARA group experienced a delayed onset and reduced incidence of respiratory issues, indicating potential benefits of early nutrition on long-term health.
Read More
Most Useful Reviews
9
Prevents illness
131 people found this helpful
I've been taking Omega-3 daily for four months, and I haven't caught a common cold. I experienced outbreaks of herpes after a two-month break, so I'll resume taking it. If my review helped you, please like it.
Read More
9
Energising effects
19 people found this helpful
I was surprised by how refreshing Omega-3 is. Within days, I felt an improvement in my health and more energy. Waking up was much easier. The price is good for 200 capsules, and the quality of the product is high. Omega-3s are essential for heart health and reducing inflammation. They are vital for maintaining good health.
Read More
9
Weight loss
6 people found this helpful
I completed an Omega-3 course for cholesterol, and I'm pleased with the results—better immunity, fewer colds, and a noticeable weight loss of 7 kg. I'll order more as I found it beneficial for my health!
Read More
Medical Researches
SCIENTIFIC SCORE
Possibly Effective
Based on 3 Researches
7.7
- All Researches
8
We investigated whether feeding infants formula supplemented with docosahexaenoic acid (DHA) and arachidonic acid (ARA) could impact the development of allergies and respiratory illnesses until age three.
In a well-structured, randomized, double-blind study, we followed children who received either supplemented or nonsupplemented formulas during their first year of life. Our findings showed that those on the DHA/ARA formula had significantly lower chances of developing upper respiratory infections and common allergic diseases.
Notably, the DHA/ARA group experienced a delayed onset and reduced incidence of respiratory issues, indicating potential benefits of early nutrition on long-term health.
In a well-structured, randomized, double-blind study, we followed children who received either supplemented or nonsupplemented formulas during their first year of life. Our findings showed that those on the DHA/ARA formula had significantly lower chances of developing upper respiratory infections and common allergic diseases.
Notably, the DHA/ARA group experienced a delayed onset and reduced incidence of respiratory issues, indicating potential benefits of early nutrition on long-term health.
Read More
8
We conducted a double-blind randomized controlled trial to understand how prenatal supplementation of docosahexaenoic acid (DHA) might influence infant health, particularly concerning the common cold. Pregnant women were given either a daily dose of 400 mg of DHA or a placebo starting at 18 to 22 weeks of gestation until childbirth.
Caregivers then reported on their infants’ health at 1, 3, and 6 months, sharing details about common illness symptoms. We found that DHA supplementation appeared to reduce the number of colds at one month and also seemed to lessen the duration of various cold symptoms in infants. Specifically, infants in the DHA group experienced fewer cold symptoms and had shorter durations of cough and wheezing.
While the overall occurrence of specific illness symptoms was similar between the DHA and placebo groups, DHA did bring about noteworthy benefits. At 1 month, infants in the DHA group had a 26% shorter duration of cough and 30% shorter wheezing; however, they experienced a longer duration of rash.
Furthermore, by the time the infants reached 3 months, those whose mothers took DHA were ill for 14% less time overall. At 6 months, the DHA group showed significantly reduced durations of several illness indicators, although they did experience longer episodes of vomiting.
This study suggests that prenatal DHA not only seems to impact the occurrence of colds in children but may also play a role in the duration of symptoms over the first half-year of life.
Caregivers then reported on their infants’ health at 1, 3, and 6 months, sharing details about common illness symptoms. We found that DHA supplementation appeared to reduce the number of colds at one month and also seemed to lessen the duration of various cold symptoms in infants. Specifically, infants in the DHA group experienced fewer cold symptoms and had shorter durations of cough and wheezing.
While the overall occurrence of specific illness symptoms was similar between the DHA and placebo groups, DHA did bring about noteworthy benefits. At 1 month, infants in the DHA group had a 26% shorter duration of cough and 30% shorter wheezing; however, they experienced a longer duration of rash.
Furthermore, by the time the infants reached 3 months, those whose mothers took DHA were ill for 14% less time overall. At 6 months, the DHA group showed significantly reduced durations of several illness indicators, although they did experience longer episodes of vomiting.
This study suggests that prenatal DHA not only seems to impact the occurrence of colds in children but may also play a role in the duration of symptoms over the first half-year of life.
Read More
7
We examined the MITIGATE study, focusing on the effects of icosapent ethyl (IPE), a purified omega-3 fatty acid, in adults with cardiovascular disease at risk for viral upper respiratory infections.
With about 16,500 participants, this clinical trial compared IPE treatment against usual care. The goal was to see if IPE could lessen the severity and impact of viral infections over six months.
Unfortunately, there was no significant evidence found that IPE improved outcomes for upper respiratory infections in this group.
With about 16,500 participants, this clinical trial compared IPE treatment against usual care. The goal was to see if IPE could lessen the severity and impact of viral infections over six months.
Unfortunately, there was no significant evidence found that IPE improved outcomes for upper respiratory infections in this group.
Read More
User Reviews
USERS' SCORE
Good
Based on 28 Reviews
8.1
- All Reviews
- Positive Reviews
- Negative Reviews
9
Prevents illness
131 people found this helpful
I've been taking Omega-3 daily for four months, and I haven't caught a common cold. I experienced outbreaks of herpes after a two-month break, so I'll resume taking it. If my review helped you, please like it.
Read More
9
Energising effects
19 people found this helpful
I was surprised by how refreshing Omega-3 is. Within days, I felt an improvement in my health and more energy. Waking up was much easier. The price is good for 200 capsules, and the quality of the product is high. Omega-3s are essential for heart health and reducing inflammation. They are vital for maintaining good health.
Read More
9
Weight loss
6 people found this helpful
I completed an Omega-3 course for cholesterol, and I'm pleased with the results—better immunity, fewer colds, and a noticeable weight loss of 7 kg. I'll order more as I found it beneficial for my health!
Read More
9
Skin improvements
3 people found this helpful
Delight! I’ve been taking omega for the second winter season and it has exceeded my expectations. My hands no longer crack or dry, plus I feel more awake during winter. A lovely side effect has been my glowing skin. If you find my review useful, please let me know!
Read More
9
Significant coldness relief
2 people found this helpful
Since I started taking this over a year and a half ago, I barely notice the coldness in my limbs. I've struggled with this since my twenties. I continue taking one tablet a day post-supper, finding it beneficial for my coldness and skin.
Read More
Frequently Asked Questions
9
Improved immunity
17 people found this helpful
Bought this for my husband and me, and we adore it! After a month of use, we've noticed our immunity improving, as we rarely catch the common cold. My skin looks more radiant and dewy. They are easy to swallow despite their size, and the quality is excellent at an economical price. Being from a reliable company, I trust this product in these challenging times when many sell counterfeit supplements. If you find my review helpful, please thumbs up! Thank you!
9
Prevents illness
131 people found this helpful
I've been taking Omega-3 daily for four months, and I haven't caught a common cold. I experienced outbreaks of herpes after a two-month break, so I'll resume taking it. If my review helped you, please like it.
7.5
Viral disease aid
3 people found this helpful
I find this good omega beneficial as a preventative measure. With 200 capsules, I take it twice a day for three months. The price is affordable and it aids in recovering from the common cold, especially during the autumn months when I begin taking it to combat viral diseases.
7.5
Better health
17 people found this helpful
Omega-3 has improved my immunity; I no longer suffer from common colds, headaches have disappeared, and I've experienced a surge in energy. A remarkable product!
9
Reduced illness
2 people found this helpful
Good value for money! My husband has been taking this all winter and, thankfully, hardly got sick. The common cold didn't significantly affect him. We’re satisfied with this omega and I've ordered more for my parents.
9
Energising effects
19 people found this helpful
I was surprised by how refreshing Omega-3 is. Within days, I felt an improvement in my health and more energy. Waking up was much easier. The price is good for 200 capsules, and the quality of the product is high. Omega-3s are essential for heart health and reducing inflammation. They are vital for maintaining good health.
9
Significant coldness relief
2 people found this helpful
Since I started taking this over a year and a half ago, I barely notice the coldness in my limbs. I've struggled with this since my twenties. I continue taking one tablet a day post-supper, finding it beneficial for my coldness and skin.
7.5
Less coldness overall
3 people found this helpful
There has been an improvement in my coldness. Alongside vitamin B and kalmag, I felt less cold and irritation around my menstruation. My head feels clearer, but I do struggle to wake up in the mornings (lol).
8
Effective for veins
5 people found this helpful
After 100 days of omega-3 supplementation, I found it beneficial for my veins although it didn’t correct my hormonal issues. I’ve neither caught the common cold nor felt ill throughout the autumn and winter. I attribute this partly to other supplements but thankful for the omega's role. If my review was helpful, please like it!
7.5
Stronger immunity
2 people found this helpful
This supplement is great for boosting my immunity. I notice having fewer colds and if I do get ill, I recover quickly.
7.5
Improved cold resilience
It took me some time to become a fan of iHerb. I initially tested the NOW Foods Omega 3 capsules. The recommended dosage is two capsules twice daily with meals, which I followed. I noticed a decrease in shortness of breath and found it easier to handle common colds, with my temperature not rising too much. Overall, it seems these omega-3 supplements have potentially improved my heart health and immunity. I have continued to order them due to the benefits I've experienced.
8
Increased immunity
5 people found this helpful
My family enjoys Omega-3, taking one capsule daily with meals. We’re in the cold season but remain unaffected by the common cold. After three months, I increased my intake to 6-7 capsules daily, which has alleviated my headaches.
9
Weight loss
6 people found this helpful
I completed an Omega-3 course for cholesterol, and I'm pleased with the results—better immunity, fewer colds, and a noticeable weight loss of 7 kg. I'll order more as I found it beneficial for my health!
7
We examined the MITIGATE study, focusing on the effects of icosapent ethyl (IPE), a purified omega-3 fatty acid, in adults with cardiovascular disease at risk for viral upper respiratory infections.
With about 16,500 participants, this clinical trial compared IPE treatment against usual care. The goal was to see if IPE could lessen the severity and impact of viral infections over six months.
Unfortunately, there was no significant evidence found that IPE improved outcomes for upper respiratory infections in this group.
With about 16,500 participants, this clinical trial compared IPE treatment against usual care. The goal was to see if IPE could lessen the severity and impact of viral infections over six months.
Unfortunately, there was no significant evidence found that IPE improved outcomes for upper respiratory infections in this group.
8
We investigated whether feeding infants formula supplemented with docosahexaenoic acid (DHA) and arachidonic acid (ARA) could impact the development of allergies and respiratory illnesses until age three.
In a well-structured, randomized, double-blind study, we followed children who received either supplemented or nonsupplemented formulas during their first year of life. Our findings showed that those on the DHA/ARA formula had significantly lower chances of developing upper respiratory infections and common allergic diseases.
Notably, the DHA/ARA group experienced a delayed onset and reduced incidence of respiratory issues, indicating potential benefits of early nutrition on long-term health.
In a well-structured, randomized, double-blind study, we followed children who received either supplemented or nonsupplemented formulas during their first year of life. Our findings showed that those on the DHA/ARA formula had significantly lower chances of developing upper respiratory infections and common allergic diseases.
Notably, the DHA/ARA group experienced a delayed onset and reduced incidence of respiratory issues, indicating potential benefits of early nutrition on long-term health.
8
We conducted a double-blind randomized controlled trial to understand how prenatal supplementation of docosahexaenoic acid (DHA) might influence infant health, particularly concerning the common cold. Pregnant women were given either a daily dose of 400 mg of DHA or a placebo starting at 18 to 22 weeks of gestation until childbirth.
Caregivers then reported on their infants’ health at 1, 3, and 6 months, sharing details about common illness symptoms. We found that DHA supplementation appeared to reduce the number of colds at one month and also seemed to lessen the duration of various cold symptoms in infants. Specifically, infants in the DHA group experienced fewer cold symptoms and had shorter durations of cough and wheezing.
While the overall occurrence of specific illness symptoms was similar between the DHA and placebo groups, DHA did bring about noteworthy benefits. At 1 month, infants in the DHA group had a 26% shorter duration of cough and 30% shorter wheezing; however, they experienced a longer duration of rash.
Furthermore, by the time the infants reached 3 months, those whose mothers took DHA were ill for 14% less time overall. At 6 months, the DHA group showed significantly reduced durations of several illness indicators, although they did experience longer episodes of vomiting.
This study suggests that prenatal DHA not only seems to impact the occurrence of colds in children but may also play a role in the duration of symptoms over the first half-year of life.
Caregivers then reported on their infants’ health at 1, 3, and 6 months, sharing details about common illness symptoms. We found that DHA supplementation appeared to reduce the number of colds at one month and also seemed to lessen the duration of various cold symptoms in infants. Specifically, infants in the DHA group experienced fewer cold symptoms and had shorter durations of cough and wheezing.
While the overall occurrence of specific illness symptoms was similar between the DHA and placebo groups, DHA did bring about noteworthy benefits. At 1 month, infants in the DHA group had a 26% shorter duration of cough and 30% shorter wheezing; however, they experienced a longer duration of rash.
Furthermore, by the time the infants reached 3 months, those whose mothers took DHA were ill for 14% less time overall. At 6 months, the DHA group showed significantly reduced durations of several illness indicators, although they did experience longer episodes of vomiting.
This study suggests that prenatal DHA not only seems to impact the occurrence of colds in children but may also play a role in the duration of symptoms over the first half-year of life.
References
- Ambrosy AP, Malik UI, Thomas RC, Parikh RV, Tan TC, et al. Rationale and design of the pragmatic randomized trial of icosapent ethyl for high cardiovascular risk adults (MITIGATE). Am Heart J. 2021;235:54. 10.1016/j.ahj.2021.01.018
- Birch EE, Khoury JC, Berseth CL, Castañeda YS, Couch JM, et al. The impact of early nutrition on incidence of allergic manifestations and common respiratory illnesses in children. J Pediatr. 2010;156:902. 10.1016/j.jpeds.2010.01.002
- Imhoff-Kunsch B, Stein AD, Martorell R, Parra-Cabrera S, Romieu I, et al. Prenatal docosahexaenoic acid supplementation and infant morbidity: randomized controlled trial. Pediatrics. 2011;128:e505. 10.1542/peds.2010-1386
